Health Freedom

Letter to DEA Administrator Tandy on ending monopoly on research

At present, the National Institute on Drug Abuse (NIDA) has a monopoly on the production of marijuana for legitimate medical and research purposes in the United States. Judge Bittner found this monopoly to be unjustified, since federal law clearly requires adequate competition in the manufacture of Schedule I and II substances. (See 21 U.S.C. § 823(a)(1); see also 21 C.F.R. § 1301.33(b).)  

Protect Health Freedom

The purpose of this letter is to alert Congress to the opportunity it has to protect the health of the American people by protecting a certain section in the "Food and Drug Administration (FDA) Revitalization Act" (S. 1082 and HR 2900), and overriding recent FDA Guidance threatening consumer access to natural therapies.
Syndicate content